Fully human monoclonal antibodies to TRAIL-R1 enhance TRAIL-induced apoptosis via activation of caspase-8 pathway
Keywords: TRAIL; TRAIL-R1; Fully human monoclonal antibodies to TRAIL-R1; Apoptosis; Tumor immunotherapy; TRAIL; Tumor necrosis factor-related apoptosis-inducing ligand; TRAIL-R; TRAIL receptors; TR1-mAbs; monoclonal antibodies against TRAIL-R1; E-TR1-Ab; Enhancing